Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, and RNA modifications and cancer.
The mutagenic forces shaping the genomes of lung cancer in never smokers
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during aging
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee
<i>SMARCA4</i> alterations in non-small cell lung cancer: a systematic review and meta-analysis
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic review and meta-analysis
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
Interim Storage of Biospecimen at Satellite Collection Centers: Dewar and Cryotube Choice Are Important for Temporary Storage in Liquid Nitrogen
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
Targeting netrin‐3 in small cell lung cancer and neuroblastoma
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists